Novadip Biosciences is a biopharmaceutical company founded to design, develop and bring to the market innovative stem cell-based therapies for regenerative medicine. The first proprietary cellular therapy of Novadip Biosciences is a totally differentiated and 3D osteogenic scaffold-free structure which provide innovative treatments for severe bone healing disorders.
Their lead product NVD-001 introduces new principles of guided tissue regeneration based on stem cells from fatty tissue, associated to osteoinductive, osteoconductive and osteogenic properties to manufacture 3D natural bone implants with the right shape, mineralization and all mechanical properties for replacement and repair of large bone defects.
In September 2015, NOVADIP has closed EUR 28 million Series A Round with US and Belgian investors to advance his breakthrough cell therapy pipeline.
Phone number : +32/10 77 92 20
E-mail : info@novadip.com
VAT : BE0535.575.602
Privacy policy : https://www.novadip.com/privacy-policy-2/
Location: Belgium, Walloon Brabant, Mont-Saint-Guibert
Employees: 11-50
Total raised: $92.85M
Founded date: 2013
Investors 4
| Date | Name | Website |
| - | Invest.BW | investbw.b... |
| - | Fund+ | fundplus.b... |
| - | Le Groupe ... | sriw.be |
| - | New Scienc... | newscience... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 04.11.2022 | Series B | $39.19M | - |
| 28.10.2021 | Series B | $22.05M | - |
| 10.09.2015 | Series A | $31.6M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 27.12.2022 | Novadip Biosciences SA Appoints Judy Ashworth, MD, as Chief ... | Mont Saint-Guibert, Belgium – December 27, 2022 – Novadip Biosciences SA (“Novadip” or “the Company”... | fundplus.b... |
| 09.12.2022 | Novadip Biosciences SA Announces Positive Results from Phase... | Study results demonstrate NVD-003 has a favorable safety profile and convincing efficacy including r... | fundplus.b... |
| 04.11.2022 | Novadip Biosciences Raises Additional EUR 40 Million Bringin... | Funding will support development of next generation orthopedic products that provide accelerated hea... | fundplus.b... |
| 03.11.2022 | Novadip Biosciences Raises Additional EUR 40M in Series B Fu... | Novadip Biosciences, a Mont Saint-Guibert, Belgium-based clinical-stage biopharmaceutical company de... | finsmes.co... |
| 20.12.2021 | Intertrust N : Why investors should check out Belgium's worl... | Make an enquiry The country's industrial heritage allied with strong government incentives to help ... | marketscre... |
| 28.10.2021 | Novadip Biosciences announces EUR 19 million Series B financ... | Novadip Biosciences announces EUR 19 million Series B financing backed by international investors N... | fundplus.b... |
| 28.10.2021 | Novadip Biosciences announces EUR 19 million Series B financ... | Novadip Biosciences announces EUR 19 million Series B financing backed by international investors N... | marketscre... |
| 28.10.2021 | Novadip Biosciences announces EUR 19 million Series B financ... | Novadip Biosciences announces EUR 19 million Series B financing backed by international investors N... | globenewsw... |
| 10.09.2015 | Novadip Biosciences Closes €28M Series A Financing | Novadip Biosciences, a biopharmaceutical spin-off company of Université catholique de Louvain, Belgi... | finsmes.co... |
| 09.09.2015 | Daily funding roundup - September 9, 2015 | Didi Kuaidi scored $1B; Chef bagged $40M; Primus Power raised $25M The battle for supremacy among e... | vator.tv/n... |
Show more